Macrophage-derived reactive oxygen species suppress miR-328 targeting CD44 in cancer cells and promote redox adaptation

Takatsugu Ishimoto, Hidetaka Sugihara, Masayuki Watanabe, Hiroshi Sawayama, Masaaki Iwatsuki, Yoshifumi Baba, Hirohisa Okabe, Kosei Hidaka, Naomi Yokoyama, Keisuke Miyake, Momoko Yoshikawa, Osamu Nagano, Yoshihiro Komohara, Motohiro Takeya, Hideyuki Saya, Hideo Baba

研究成果: Article

53 引用 (Scopus)

抄録

CD44 is frequently overexpressed in a wide variety of epithelial malignancies including gastrointestinal cancer and causes resistance to currently available treatments. MicroRNAs (miRNAs) are non-coding RNAs that regulate molecular pathways in cancer by targeting various genes. The aim of this study was to investigate the regulation of CD44 expression by miRNAs and to develop new molecular targets in gastrointestinal cancer. We performed miRNA screening in six human gastrointestinal cancer cell lines and identified three candidate miRNAs that could regulate CD44 expression in gastrointestinal cancer. Among these, we focused on miR-328 and examined its functional relevance using growth assays and cytotoxicity assays. CD44 expression was reduced in gastrointestinal cancer cell lines forced to express miR-328, leading to inhibition of cancer cell growth in vitro and in vivo, and impaired resistance to chemotherapeutic drugs and reactive oxygen species (ROS). In contrast, induction of CD44 expression by miR-328 inhibitor led to promotion of cancer cell growth. Furthermore, we revealed that ROS produced by macrophages triggered CD44 expression through suppression of miR-328 in gastric cancer cells. Finally, tumor-infiltrating macrophages (CD68 and CD163) were closely related to both miR-328 downregulation and CD44 upregulation in 63 patients with surgically resected gastric cancer. These findings suggest that macrophages in the tumor microenvironment may cause increased CD44 expression through miR-328 suppression, resulting in tumor progression by enhancing ROS defense. miR-328-CD44 signaling mediated by macrophages may thus represent a potential target for the treatment of gastrointestinal cancer.

元の言語English
ページ(範囲)1003-1011
ページ数9
ジャーナルCarcinogenesis
35
発行部数5
DOI
出版物ステータスPublished - 2014

Fingerprint

Gastrointestinal Neoplasms
Oxidation-Reduction
Reactive Oxygen Species
Macrophages
MicroRNAs
Neoplasms
Stomach Neoplasms
Growth
Cell Line
Untranslated RNA
Tumor Microenvironment
Gene Targeting
Up-Regulation
Down-Regulation
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cancer Research

これを引用

Ishimoto, T., Sugihara, H., Watanabe, M., Sawayama, H., Iwatsuki, M., Baba, Y., ... Baba, H. (2014). Macrophage-derived reactive oxygen species suppress miR-328 targeting CD44 in cancer cells and promote redox adaptation. Carcinogenesis, 35(5), 1003-1011. https://doi.org/10.1093/carcin/bgt402

Macrophage-derived reactive oxygen species suppress miR-328 targeting CD44 in cancer cells and promote redox adaptation. / Ishimoto, Takatsugu; Sugihara, Hidetaka; Watanabe, Masayuki; Sawayama, Hiroshi; Iwatsuki, Masaaki; Baba, Yoshifumi; Okabe, Hirohisa; Hidaka, Kosei; Yokoyama, Naomi; Miyake, Keisuke; Yoshikawa, Momoko; Nagano, Osamu; Komohara, Yoshihiro; Takeya, Motohiro; Saya, Hideyuki; Baba, Hideo.

:: Carcinogenesis, 巻 35, 番号 5, 2014, p. 1003-1011.

研究成果: Article

Ishimoto, T, Sugihara, H, Watanabe, M, Sawayama, H, Iwatsuki, M, Baba, Y, Okabe, H, Hidaka, K, Yokoyama, N, Miyake, K, Yoshikawa, M, Nagano, O, Komohara, Y, Takeya, M, Saya, H & Baba, H 2014, 'Macrophage-derived reactive oxygen species suppress miR-328 targeting CD44 in cancer cells and promote redox adaptation', Carcinogenesis, 巻. 35, 番号 5, pp. 1003-1011. https://doi.org/10.1093/carcin/bgt402
Ishimoto, Takatsugu ; Sugihara, Hidetaka ; Watanabe, Masayuki ; Sawayama, Hiroshi ; Iwatsuki, Masaaki ; Baba, Yoshifumi ; Okabe, Hirohisa ; Hidaka, Kosei ; Yokoyama, Naomi ; Miyake, Keisuke ; Yoshikawa, Momoko ; Nagano, Osamu ; Komohara, Yoshihiro ; Takeya, Motohiro ; Saya, Hideyuki ; Baba, Hideo. / Macrophage-derived reactive oxygen species suppress miR-328 targeting CD44 in cancer cells and promote redox adaptation. :: Carcinogenesis. 2014 ; 巻 35, 番号 5. pp. 1003-1011.
@article{f25e5ed442004b679f9b11c993e44ae5,
title = "Macrophage-derived reactive oxygen species suppress miR-328 targeting CD44 in cancer cells and promote redox adaptation",
abstract = "CD44 is frequently overexpressed in a wide variety of epithelial malignancies including gastrointestinal cancer and causes resistance to currently available treatments. MicroRNAs (miRNAs) are non-coding RNAs that regulate molecular pathways in cancer by targeting various genes. The aim of this study was to investigate the regulation of CD44 expression by miRNAs and to develop new molecular targets in gastrointestinal cancer. We performed miRNA screening in six human gastrointestinal cancer cell lines and identified three candidate miRNAs that could regulate CD44 expression in gastrointestinal cancer. Among these, we focused on miR-328 and examined its functional relevance using growth assays and cytotoxicity assays. CD44 expression was reduced in gastrointestinal cancer cell lines forced to express miR-328, leading to inhibition of cancer cell growth in vitro and in vivo, and impaired resistance to chemotherapeutic drugs and reactive oxygen species (ROS). In contrast, induction of CD44 expression by miR-328 inhibitor led to promotion of cancer cell growth. Furthermore, we revealed that ROS produced by macrophages triggered CD44 expression through suppression of miR-328 in gastric cancer cells. Finally, tumor-infiltrating macrophages (CD68 and CD163) were closely related to both miR-328 downregulation and CD44 upregulation in 63 patients with surgically resected gastric cancer. These findings suggest that macrophages in the tumor microenvironment may cause increased CD44 expression through miR-328 suppression, resulting in tumor progression by enhancing ROS defense. miR-328-CD44 signaling mediated by macrophages may thus represent a potential target for the treatment of gastrointestinal cancer.",
author = "Takatsugu Ishimoto and Hidetaka Sugihara and Masayuki Watanabe and Hiroshi Sawayama and Masaaki Iwatsuki and Yoshifumi Baba and Hirohisa Okabe and Kosei Hidaka and Naomi Yokoyama and Keisuke Miyake and Momoko Yoshikawa and Osamu Nagano and Yoshihiro Komohara and Motohiro Takeya and Hideyuki Saya and Hideo Baba",
year = "2014",
doi = "10.1093/carcin/bgt402",
language = "English",
volume = "35",
pages = "1003--1011",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Macrophage-derived reactive oxygen species suppress miR-328 targeting CD44 in cancer cells and promote redox adaptation

AU - Ishimoto, Takatsugu

AU - Sugihara, Hidetaka

AU - Watanabe, Masayuki

AU - Sawayama, Hiroshi

AU - Iwatsuki, Masaaki

AU - Baba, Yoshifumi

AU - Okabe, Hirohisa

AU - Hidaka, Kosei

AU - Yokoyama, Naomi

AU - Miyake, Keisuke

AU - Yoshikawa, Momoko

AU - Nagano, Osamu

AU - Komohara, Yoshihiro

AU - Takeya, Motohiro

AU - Saya, Hideyuki

AU - Baba, Hideo

PY - 2014

Y1 - 2014

N2 - CD44 is frequently overexpressed in a wide variety of epithelial malignancies including gastrointestinal cancer and causes resistance to currently available treatments. MicroRNAs (miRNAs) are non-coding RNAs that regulate molecular pathways in cancer by targeting various genes. The aim of this study was to investigate the regulation of CD44 expression by miRNAs and to develop new molecular targets in gastrointestinal cancer. We performed miRNA screening in six human gastrointestinal cancer cell lines and identified three candidate miRNAs that could regulate CD44 expression in gastrointestinal cancer. Among these, we focused on miR-328 and examined its functional relevance using growth assays and cytotoxicity assays. CD44 expression was reduced in gastrointestinal cancer cell lines forced to express miR-328, leading to inhibition of cancer cell growth in vitro and in vivo, and impaired resistance to chemotherapeutic drugs and reactive oxygen species (ROS). In contrast, induction of CD44 expression by miR-328 inhibitor led to promotion of cancer cell growth. Furthermore, we revealed that ROS produced by macrophages triggered CD44 expression through suppression of miR-328 in gastric cancer cells. Finally, tumor-infiltrating macrophages (CD68 and CD163) were closely related to both miR-328 downregulation and CD44 upregulation in 63 patients with surgically resected gastric cancer. These findings suggest that macrophages in the tumor microenvironment may cause increased CD44 expression through miR-328 suppression, resulting in tumor progression by enhancing ROS defense. miR-328-CD44 signaling mediated by macrophages may thus represent a potential target for the treatment of gastrointestinal cancer.

AB - CD44 is frequently overexpressed in a wide variety of epithelial malignancies including gastrointestinal cancer and causes resistance to currently available treatments. MicroRNAs (miRNAs) are non-coding RNAs that regulate molecular pathways in cancer by targeting various genes. The aim of this study was to investigate the regulation of CD44 expression by miRNAs and to develop new molecular targets in gastrointestinal cancer. We performed miRNA screening in six human gastrointestinal cancer cell lines and identified three candidate miRNAs that could regulate CD44 expression in gastrointestinal cancer. Among these, we focused on miR-328 and examined its functional relevance using growth assays and cytotoxicity assays. CD44 expression was reduced in gastrointestinal cancer cell lines forced to express miR-328, leading to inhibition of cancer cell growth in vitro and in vivo, and impaired resistance to chemotherapeutic drugs and reactive oxygen species (ROS). In contrast, induction of CD44 expression by miR-328 inhibitor led to promotion of cancer cell growth. Furthermore, we revealed that ROS produced by macrophages triggered CD44 expression through suppression of miR-328 in gastric cancer cells. Finally, tumor-infiltrating macrophages (CD68 and CD163) were closely related to both miR-328 downregulation and CD44 upregulation in 63 patients with surgically resected gastric cancer. These findings suggest that macrophages in the tumor microenvironment may cause increased CD44 expression through miR-328 suppression, resulting in tumor progression by enhancing ROS defense. miR-328-CD44 signaling mediated by macrophages may thus represent a potential target for the treatment of gastrointestinal cancer.

UR - http://www.scopus.com/inward/record.url?scp=84901986092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901986092&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgt402

DO - 10.1093/carcin/bgt402

M3 - Article

C2 - 24318997

AN - SCOPUS:84901986092

VL - 35

SP - 1003

EP - 1011

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 5

ER -